David E I Pyott

Type: Person

Name: David E I Pyott

Title: Chairman & CEO

Organization: Allergan

Nationality: United Kingdom

First reported May 13 2013 - Updated May 13 2013 - 1 reports

MAP Pharmaceuticals Inc

Allergan reports lower Q1 net income, provides guidance for Q2 and 2013

Allergan, Inc., a healthcare company, has reported that net income attributable to the company for the first quarter ended March 31, 2013 was $12.5 million, or $0.04 per diluted share, compared to $229.8 million, or $0.74 per diluted share, for the same ... [Published Individual.com - May 13 2013]

Entities: Allergan Inc, David E I Pyott, SkinMedica Inc, LEVADEX, MAP Pharmaceuticals Inc

First reported May 04 2013 - Updated May 04 2013 - 1 reports

Toll Brothers Inc

The Memory-Free Market

Written by: Jim Cramer 05/04/13 - 7:45 AM EDTTickers in this article: COP MMM MSFT TOL VFCTHIS COLLECTION OF POSTS ORIGINALLY APPEARED ON MAY 2, 2013 ON REAL MONEY. TO READ MORE CONTENT LIKE THIS + SEE INSIDE JIM CRAMER'S MULTI-MILLION DOLLAR PORTFOLIO ... [Published Leavenworth Times - May 04 2013]

Entities: Market, David E I Pyott, Toll Brothers Inc, VF Corporation, Allergan Inc

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Richer Than You

As a general rule, the most successful man in life is the man who has the best informationIncome inequality in Canada and the United States is on the rise. Most of the published articles today, as to why income inequality is rising, are dead wrong. Read ... [Published Safe Haven - May 03 2013]

Entities: one percent, Inequality, Canadian Centre for Policy Alternatives, Canada

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Jim Cramer

Recent Dip May Provide Long-Term Opportunity on Allergan (AGN) - Cramer

Allergan (NYSE: AGN) is on the mend Friday following a rough post-earnings week. The bounce may be due in part to CEO, chairman, and president David Pyott speaking with stock sage Jim Cramer on Thursday night.Pyott noted a positive FDA committee recommendation ... [Published Street Insider - May 03 2013]

Entities: Allergan Inc, Jim Cramer, David E I Pyott, Drugs, Share Price

First reported May 03 2013 - Updated May 03 2013 - 1 reports

BIO Elects New Chair, Officers, and Board Members

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- The Biotechnology Industry Organization (BIO) is pleased to announce the election of Rachel King, President and CEO, GlycoMimetics, Inc, as the new Chair of its Board of Directors ... [Published NewsRX - May 03 2013]

Entities: GlycoMimetics Inc, Elections, David E I Pyott, Rachel King

First reported May 02 2013 - Updated May 03 2013 - 1 reports

Allergan Inc

Allergan CEO: FDA Voted In Favor of Voluma

Allergan reported positive earnings on Wednesday, but the stock tumbled after. Its CEO David Pyott discusses earnings, drug delays and the future of the company. ... [Published CNBC - May 02 2013]

Entities: Allergan Inc, David E I Pyott, Drugs

First reported May 01 2013 - Updated May 02 2013 - 1 reports

UPDATE 1-Allergan delays eye drug, shares fall

5:11pm BSTBy May 1 (Reuters) - Allergan Inc, maker of the Botox anti-wrinkle treatment, said it will delay late-stage trials of its highly anticipated eye drug Darpin, sending its shares down 14 percent.Shares in Regeneron Pharmaceuticals Inc rose 14 ... [Published Reuters UK - May 01 2013]

Entities: Allergan Inc, Botox, Eylea, Drugs

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Allergan stock drops on delays

Shares of Allergan Inc. fell sharply Wednesday after the Irvine-based pharmaceutical company said it would delay final testing on two of the most promising drugs in its pipeline.The company's CEO, David Pyott, told analysts and investors that... ... [Published Orange County Register - May 02 2013]

Entities: Allergan Inc, David E I Pyott, Drugs

First reported May 01 2013 - Updated May 01 2013 - 2 reports

Allergan Management Discusses Q1 2013 Results - Earnings Call Transcript

11:00 AM ETOperatorHello, and welcome to the Allergan First Quarter 2013 Earnings Call. [Operator Instructions] At the request of the company, today's conference is being recorded. If anyone has any objections, you may disconnect at this time.I would ... [Published Seeking Alpha - May 01 2013]

Entities: Allergan Inc, Botox, Overactive Bladder, Continuing Operations

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Notable 52-Week Highs and Lows of the Day 05/01: (SIRI) (VIAB) (REGN) High; (ANV) (MELA) Low

Sirius XM (Nasdaq: SIRI) $3.39. Sirius moving higher amid reporting mixed Q1 results and guidance Tuesday, as well as appointing a new CEO.Viacom (Nasdaq: VIAB) high of $69.00. Viacom reported Q2 EPS of 96 cents on revs of $3.14 billion, with consensus ... [Published Street Insider - May 01 2013]

Entities: Mela Sciences Inc, Viacom Inc, David E I Pyott, Eylea, Mueller Water Products Inc

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Allergan Evaluates Bids for its Lap-Band Weight Loss Product

Allergan Inc. (AGN), the maker of the Botox wrinkle treatment, said it is evaluating offers for the company’s Lap-Band weight loss product and the rest of the obesity-treatment unit.The Botox maker, which reclassified the obesity unit as a discontinued ... [Published Bloomberg - May 01 2013]

Entities: Allergan Inc, Weight Loss, Botox, David E I Pyott, Obesity

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

America’s Top 15 Most Highly Paid Pharmaceutical Industry CEOs of 2012

Here is a list of America’s Top 15 most highly paid CEOs in the pharmaceutical industry in 2012, drawn from this Forbes list of CEO pay . The figures are for 1-year pay. John H Hammergren – McKesson – $131.19 million George Paz – Express Scripts – $51.52 ... [Published Terrapinn - Apr 23 2013]

Entities: Kevin W. Sharer, Ian C Read, Robert L Parkinson, Leonard Bell

More Content

sort by: Date \| Relevance
Allergan reports lower Q1 net income, provides ... [Published Individual.com - May 13 2013]
Allergan Releases 1Q 2013 Operating Results [Published Individual.com - May 06 2013]
The Memory-Free Market [Published Leavenworth Times - May 04 2013]
Richer Than You [Published Safe Haven - May 03 2013]
Income Inequality - Richer Than You [Published Market Oracle - May 03 2013]
Recent Dip May Provide Long-Term Opportunity on... [Published Street Insider - May 03 2013]
East Coast Life Sciences Roundup: Aveo, Forma, ... [Published Xconomy - May 03 2013]
BIO Elects New Chair, Officers, and Board Members [Published NewsRX - May 03 2013]
Allergan CEO: FDA Voted In Favor of Voluma [Published CNBC - May 02 2013]
Allergan stock drops on drug delays [Published Equities.com - May 02 2013]
Allergan stock drops on delays [Published Orange County Register - May 02 2013]
US stocks decline on economic data [Published Melbourne Age - May 01 2013]
Allergan Management Discusses Q1 2013 Results -... [Published Seeking Alpha - May 01 2013]
Notable 52-Week Highs and Lows of the Day 05/01... [Published Street Insider - May 01 2013]
Allergan slides, Regeneron surges on eye drug news [Published CNBC - May 01 2013]
UPDATE 2-Allergan delays drug that would rival ... [Published Reuters - May 01 2013]
Allergan Plunges After Two Medicine Trials are ... [Published Washington Post - May 01 2013]
Unusual 11 Mid-Day Movers 05/01: (IQNT) (BCOV) ... [Published Street Insider - May 01 2013]
Allergan Shares Fall After CEO Says Two Studies... [Published Bloomberg - May 01 2013]
Allergan Reports Drug Development Delay, Lower ... [Published 4 Traders - May 01 2013]
UPDATE 1-Allergan delays eye drug, shares fall [Published Reuters UK - May 01 2013]
Allergan Evaluates Bids for its Lap-Band Weight... [Published Bloomberg - May 01 2013]
Allergan Q1 Results Top Estimates; Cuts 2013 EP... [Published RTTNews.com - May 01 2013]
ALLERGAN, INC.: Allergan Announces Death of Ste... [Published 4 Traders - Apr 30 2013]
Allergan Announces Death of Stephen J. Ryan, M.D. [Published Individual.com - Apr 30 2013]
Allergan Announces Death of Stephen J. Ryan, M.D. [Published Business Wire Health News - Apr 30 2013]
America’s Top 15 Most Highly Paid Pharmaceutica... [Published Terrapinn - Apr 23 2013]
BIO Elects New Chair, Officers, and Board Members [Published NewsBlaze - Apr 23 2013]
BIO Elects New Chair, Officers, and Board Members [Published Business Wire - Apr 23 2013]
BIO Elects New Chair, Officers, and Board Members [Published Business Wire Science: Science News - Apr 23 2013]